Inhibition of Bradykinin Receptor B1 Protects Mice from Focal Brain Injury by Reducing Blood–Brain Barrier Leakage and Inflammation
Open Access
- 3 March 2010
- journal article
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 30 (8), 1477-1486
- https://doi.org/10.1038/jcbfm.2010.28
Abstract
Kinins are proinflammatory and vasoactive peptides that are released during tissue damage and may contribute to neuronal degeneration, inflammation, and edema formation after brain injury by acting on discrete bradykinin receptors, B1R and B2R. We studied the expression of B1R and B2R and the effect of their inhibition on lesion size, blood–brain barrier (BBB) disruption, and inflammatory processes after a focal cryolesion of the right parietal cortex in mice. B1R and B2R gene transcripts were significantly induced in the lesioned hemispheres of wild-type mice ( P −/− mice were significantly smaller than in wild-type controls (2.5±2.6 versus 11.5±3.9 mm3, P3, P<0.001). This was accompanied by a remarkable reduction of BBB disruption and tissue inflammation. In contrast, genetic deletion or pharmacological inhibition of B2R had no significant impact on lesion formation or the development of brain edema. We conclude that B1R inhibition may offer a novel therapeutic strategy after acute brain injuries.Keywords
This publication has 33 references indexed in Scilit:
- Anatibant®, a selective non-peptide bradykinin B2 receptor antagonist, reduces intracranial hypertension and histopathological damage after experimental traumatic brain injuryNeuroscience Letters, 2009
- Pathophysiology of traumatic brain injuryMount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine, 2009
- Blockade of Bradykinin Receptor B1 but Not Bradykinin Receptor B2 Provides Protection From Cerebral Infarction and Brain EdemaStroke, 2009
- Pharmacology of Traumatic Brain Injury: Where Is the “Golden Bullet”?Molecular Medicine, 2008
- The endothelin system as a therapeutic target in cardiovascular disease: great expectations or bleak house?British Journal of Pharmacology, 2008
- Mechanisms of ET-1-induced Endothelial DysfunctionJournal of Cardiovascular Pharmacology, 2007
- Global brain atrophy after unilateral parietal lesion and its prevention by erythropoietinBrain, 2005
- A systematic review of brain injury epidemiology in EuropeActa Neurochirurgica, 2005
- Targeting Kinin Receptors for the Treatment of Neurological DiseasesCurrent Pharmaceutical Design, 2005
- International Union of Pharmacology. XLV. Classification of the Kinin Receptor Family: from Molecular Mechanisms to Pathophysiological ConsequencesPharmacological Reviews, 2005